Quantitative Proteomics for Clinical Translation

Zhaohui Chen, Jennifer E. Van Eyk

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

For precision medicine to be successful, the identification and measurement of proteins that are reflective of a personal health status is key both for the development and use of circulating biomarkers and to define mechanistic pathways involved in drug responses. Prior to clinical translation, it is essential to accurately and reproducibly detect protein concentrations, their isoforms or polymorphism expression, and the many potential cotranslational and posttranslational modifications on 100-10,000 individuals. Over the last 20 years, the proteomic field has matured with respect to its approaches, methods, and instrumentation to allow for increased number of measurements per analysis. Through the use of the current, state-of-art, high precision, and accuracy mass spectrometry technology, quantitative proteomics is becoming a quantitative method able to address the needs of precision medicine.

Original languageEnglish (US)
Title of host publicationGenomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition
PublisherElsevier Inc.
Pages79-87
Number of pages9
ISBN (Print)9780128006818
DOIs
StatePublished - Dec 15 2016
Externally publishedYes

Fingerprint

Precision Medicine
Proteomics
Medicine
Biomarkers
Post Translational Protein Processing
Polymorphism
Health Status
Mass spectrometry
Mass Spectrometry
Protein Isoforms
Proteins
Health
Technology
Pharmaceutical Preparations

Keywords

  • Biomarkers
  • Disease modified
  • Mass spectrometry
  • Posttranslational modifications
  • Precision medicine
  • Proteomics
  • Quantitation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Chen, Z., & Van Eyk, J. E. (2016). Quantitative Proteomics for Clinical Translation. In Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition (pp. 79-87). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800681-8.00005-0

Quantitative Proteomics for Clinical Translation. / Chen, Zhaohui; Van Eyk, Jennifer E.

Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition. Elsevier Inc., 2016. p. 79-87.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chen, Z & Van Eyk, JE 2016, Quantitative Proteomics for Clinical Translation. in Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition. Elsevier Inc., pp. 79-87. https://doi.org/10.1016/B978-0-12-800681-8.00005-0
Chen Z, Van Eyk JE. Quantitative Proteomics for Clinical Translation. In Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition. Elsevier Inc. 2016. p. 79-87 https://doi.org/10.1016/B978-0-12-800681-8.00005-0
Chen, Zhaohui ; Van Eyk, Jennifer E. / Quantitative Proteomics for Clinical Translation. Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition. Elsevier Inc., 2016. pp. 79-87
@inbook{23c4a9de3c8b4a0580b8a75e9fcdb545,
title = "Quantitative Proteomics for Clinical Translation",
abstract = "For precision medicine to be successful, the identification and measurement of proteins that are reflective of a personal health status is key both for the development and use of circulating biomarkers and to define mechanistic pathways involved in drug responses. Prior to clinical translation, it is essential to accurately and reproducibly detect protein concentrations, their isoforms or polymorphism expression, and the many potential cotranslational and posttranslational modifications on 100-10,000 individuals. Over the last 20 years, the proteomic field has matured with respect to its approaches, methods, and instrumentation to allow for increased number of measurements per analysis. Through the use of the current, state-of-art, high precision, and accuracy mass spectrometry technology, quantitative proteomics is becoming a quantitative method able to address the needs of precision medicine.",
keywords = "Biomarkers, Disease modified, Mass spectrometry, Posttranslational modifications, Precision medicine, Proteomics, Quantitation",
author = "Zhaohui Chen and {Van Eyk}, {Jennifer E.}",
year = "2016",
month = "12",
day = "15",
doi = "10.1016/B978-0-12-800681-8.00005-0",
language = "English (US)",
isbn = "9780128006818",
pages = "79--87",
booktitle = "Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Quantitative Proteomics for Clinical Translation

AU - Chen, Zhaohui

AU - Van Eyk, Jennifer E.

PY - 2016/12/15

Y1 - 2016/12/15

N2 - For precision medicine to be successful, the identification and measurement of proteins that are reflective of a personal health status is key both for the development and use of circulating biomarkers and to define mechanistic pathways involved in drug responses. Prior to clinical translation, it is essential to accurately and reproducibly detect protein concentrations, their isoforms or polymorphism expression, and the many potential cotranslational and posttranslational modifications on 100-10,000 individuals. Over the last 20 years, the proteomic field has matured with respect to its approaches, methods, and instrumentation to allow for increased number of measurements per analysis. Through the use of the current, state-of-art, high precision, and accuracy mass spectrometry technology, quantitative proteomics is becoming a quantitative method able to address the needs of precision medicine.

AB - For precision medicine to be successful, the identification and measurement of proteins that are reflective of a personal health status is key both for the development and use of circulating biomarkers and to define mechanistic pathways involved in drug responses. Prior to clinical translation, it is essential to accurately and reproducibly detect protein concentrations, their isoforms or polymorphism expression, and the many potential cotranslational and posttranslational modifications on 100-10,000 individuals. Over the last 20 years, the proteomic field has matured with respect to its approaches, methods, and instrumentation to allow for increased number of measurements per analysis. Through the use of the current, state-of-art, high precision, and accuracy mass spectrometry technology, quantitative proteomics is becoming a quantitative method able to address the needs of precision medicine.

KW - Biomarkers

KW - Disease modified

KW - Mass spectrometry

KW - Posttranslational modifications

KW - Precision medicine

KW - Proteomics

KW - Quantitation

UR - http://www.scopus.com/inward/record.url?scp=85009917867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009917867&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800681-8.00005-0

DO - 10.1016/B978-0-12-800681-8.00005-0

M3 - Chapter

AN - SCOPUS:85009917867

SN - 9780128006818

SP - 79

EP - 87

BT - Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition

PB - Elsevier Inc.

ER -